Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Shionogi Pharma Inc. et al v. Mylan Pharmaceuticals Inc.
Case Number:
1:10-cv-01077
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 13, 2013
Mylan Settles Fortamet Patent Suit With Shionogi, Andrx
Mylan Pharmaceuticals Inc. has settled a patent infringement suit brought by Shionogi Inc. and Andrx Corp. over Mylan's bid to develop a generic equivalent of Shionogi's blood glucose drug Fortamet, Mylan announced Wednesday.
-
October 10, 2012
Mylan Settles Dispute Over Generic Orapred ODT
Mylan Inc. has entered into a licensing agreement that will allow it to sell its generic version of anti-inflammatory Orapred ODT, ending a patent infringement dispute with rivals Shionogi Pharma Inc. and Cima Labs Inc., the company announced Tuesday.